CytoSorbents Corporation (CTSO)

[cars100cars]

As a long time Zacks subscriber, I think the reports are honest and helpful. Generally, Zacks research reports are broadly based on a compilation of all the subscribing analysts who want to know what other analysts are thinking. Subscribing analysts get compiled reports back in return. As for CTSO's coverage by Zacks, it is developed by an in-house Zacks analyst. IMO, it is a fair explanation of the company's current condition and outlook. Zacks is not responsible for the decisions of CTSO management, its weaknesses nor strengths. I've been a CTSO shareholder for years and I'm patiently waiting for profitability, broad acceptance globally and in the US, and an expanded product line. These are things CTSO management have told us they will deliver. Zacks reports have reflected both the current results and management's stated goals, just as other analysts report. I've written to Brian Marxx in the past, too, and he has always responded. And here is an interesting fact. Zacks as a company does not provide any recommendation for this stock, as it does for thousands of other stocks. It is completely neutral on owning CTSO.